[15] [16] Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg depending on the indication and patient tolerance
There has been much speculation within the veterinary community about what may have caused this increase in disease, and more research is needed
This decline affects sleep quality, circadian regulation, and downstream hormonal systems
It is not a sedative, but it may make sleep feel easier and more stable," says Dasgupta
Moderate alcohol consumption is unlikely to be harmful for most people
Older patients frequently exhibit age-related cognitive decline, sarcopenia and frailty, sensory impairment, and comorbid neurodegenerative conditions, all of which complicate the interpretation of CHE testing